C-squared Pharma

Activities: Ingredients
C-squared Pharma

Trending Articles

  1. Loftware and RiseNow partner to strengthen supply chain traceability and compliance in healthcare settings The alliance pairs Loftware's SAP-integrated product identification platform with RiseNow's procurement and supply chain advisory services, delivering end-to-end...
  2. University of Birmingham develops "switchable smart gel" that could revolutionise targeted drug delivery The multi-responsive material switches between gel and liquid states under UV light or acid exposure, with acid-triggered release mechanisms offering a potential platform for...
  3. New nozzle technology for fluid bed granulation Romaco’s new FLEXIJET offers easy operation, fast cleaning and low-cost maintenance for short granulation processes
  4. Fulcrum Therapeutics merges with Slate Medicines in $245m-backed deal The all-stock merger sees Fulcrum rebuild following its pociredir discontinuation, with the combined entity focusing on SLTE-1009 — a monoclonal antibody in development for...
  5. Andelyn Biosciences partners with Queen's University Belfast for GM2 Gangliosides candidate The CGT company will use its Curator Platform to advance AAV9-GM2 towards patient dosing through a multiphase programme, supporting the University in bringing the potentially...

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

Related Content

Manufacturing
C2 PHARMA receives CEP approval for Oxybuprocaine hydrochloride

C2 PHARMA receives CEP approval for Oxybuprocaine hydrochloride

C2 PHARMA proudly announces the approval of a Certificate of Suitability (CEP) for Oxybuprocaine hydrochloride by the European Directorate for the Quality of Medicines and Health Care (EDQM)
Manufacturing
C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide
Ingredients
C2 PHARMA expands ophthalmic API portfolio with Naphazoline Hydrochloride launch

C2 PHARMA expands ophthalmic API portfolio with Naphazoline Hydrochloride launch

C2 PHARMA, the global leader in ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the launch of its latest API, Naphazoline Hydrochloride
Regulatory
C2 Pharma's Tropicamide receives CEP from the European Directorate

C2 Pharma's Tropicamide receives CEP from the European Directorate

The CEP approval of the ophthalmic drug allows C2 Pharma to distribute Tropicamide globally
Ingredients
C2 PHARMA announces upcoming launch of new oxybuprocaine hydrochloride API

C2 PHARMA announces upcoming launch of new oxybuprocaine hydrochloride API

C2 PHARMA excited to announce the upcoming launch of its new API, oxybuprocaine HCL, an ingredient that will be manufactured by manufacturing partner Laurus Labs
Ingredients
C2 Pharma to participate in DCAT Week 2024

C2 Pharma to participate in DCAT Week 2024

The C2 PHARMA team will be located in the Benjamin hotel in Suite 2202
Ingredients
C2 PHARMA receives DMF approval in China for pilocarpine nitrate

C2 PHARMA receives DMF approval in China for pilocarpine nitrate

C2 PHARMA announces the approval of a C-DMF for pilocarpine nitrate — granted on 30 October 2023 — an API manufactured by our Brazilian partner Anidro do Brasil
Subscribe now